BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 33313727)

  • 1. Designing Trials with Purpose: Pragmatic Clinical Trials of Nonpharmacological Approaches for Pain Management.
    Gordon KS; Peduzzi P; Kerns RD
    Pain Med; 2020 Dec; 21(Suppl 2):S7-S12. PubMed ID: 33313727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intervention Fidelity in Pain Pragmatic Trials for Nonpharmacologic Pain Management: Nuanced Considerations for Determining PRECIS-2 Flexibility in Delivery and Adherence.
    Kerns RD; Davis AF; Fritz JM; Keefe FJ; Peduzzi P; Rhon DI; Taylor SL; Vining R; Yu Q; Zeliadt SB; George SZ
    J Pain; 2023 Apr; 24(4):568-574. PubMed ID: 36574858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strategy for addressing research-site overlap in pragmatic clinical trials: lessons learned from the NIH-DOD-VA Pain Management Collaboratory (PMC).
    Geda M; George SZ; Burgess DJ; Scarton DV; Roddy WT; Gordon KS; Pasquina PF; Brandt CA; Kerns RD; Peduzzi P;
    Trials; 2020 Dec; 21(1):1021. PubMed ID: 33308289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of COVID-19 pandemic on nonpharmacological pain management trials in military and veteran healthcare settings: an evaluation informed by implementation science.
    Midboe AM; Javier SJ; Salsbury SA; Katsovich L; Burgess DJ; King HA; Taylor SL; Martino S; Mayer JM; Wallace RB; Der-Martirosian C; Kerns RD
    Transl Behav Med; 2023 Aug; 13(8):601-611. PubMed ID: 37030012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrating pragmatic and implementation science randomized clinical trial approaches: a PRagmatic Explanatory Continuum Indicator Summary-2 (PRECIS-2) analysis.
    Zatzick D; Palinkas L; Chambers DA; Whiteside L; Moloney K; Engstrom A; Prater L; Russo J; Wang J; Abu K; Iles-Shih M; Bulger E
    Trials; 2023 Apr; 24(1):288. PubMed ID: 37085877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using the Pragmatic-Explanatory Continuum Indicator Summary (PRECIS) model in clinical research: Application to refine a practice-based research network (PBRN) study.
    Elder WG; Munk N
    J Am Board Fam Med; 2014; 27(6):846-54. PubMed ID: 25381083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimizing the Impact of Pragmatic Clinical Trials for Veteran and Military Populations: Lessons From the Pain Management Collaboratory.
    Ali J; Antonelli M; Bastian L; Becker W; Brandt CA; Burgess DJ; Burns A; Cohen SP; Davis AF; Dearth CL; Dziura J; Edwards R; Erdos J; Farrokhi S; Fritz J; Geda M; George SZ; Goertz C; Goodie J; Hastings SN; Heapy A; Ilfeld BM; Katsovich L; Kerns RD; Kyriakides TC; Lee A; Long CR; Luther SL; Martino S; Matheny ME; McGeary D; Midboe A; Pasquina P; Peduzzi P; Raffanello M; Rhon D; Rosen M; Esposito ER; Scarton D; Hastings SN; Seal K; Silliker N; Taylor S; Taylor SL; Tsui M; Wright FS; Zeliadt S
    Mil Med; 2022 Jul; 187(7-8):179-185. PubMed ID: 34791412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the characteristics and the degree of pragmatism exhibited by pragmatic-labelled trials of antineoplastic treatments.
    Saesen R; Depreytere K; Krupianskaya K; Langeweg J; Verheecke J; Lacombe D; Huys I
    BMC Med Res Methodol; 2023 Jun; 23(1):148. PubMed ID: 37355603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pragmatic clinical trial design in emergency medicine: Study considerations and design types.
    Gettel CJ; Yiadom MYAB; Bernstein SL; Grudzen CR; Nath B; Li F; Hwang U; Hess EP; Melnick ER
    Acad Emerg Med; 2022 Oct; 29(10):1247-1257. PubMed ID: 35475533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A dynamic application of PRECIS-2 to evaluate implementation in a pragmatic, cluster randomized clinical trial in two nursing home systems.
    Palmer JA; Mor V; Volandes AE; McCreedy E; Loomer L; Carter P; Dvorchak F; Mitchell SL
    Trials; 2018 Aug; 19(1):453. PubMed ID: 30134976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stakeholder Engagement in Pragmatic Clinical Trials: Emphasizing Relationships to Improve Pain Management Delivery and Outcomes.
    Bastian LA; Cohen SP; Katsovich L; Becker WC; Brummett BR; Burgess DJ; Crunkhorn AE; Denneson LM; Frank JW; Goertz C; Ilfeld B; Kanzler KE; Krishnaswamy A; LaChappelle K; Martino S; Mattocks K; McGeary CA; Reznik TE; Rhon DI; Salsbury SA; Seal KH; Semiatin AM; Shin MH; Simon CB; Teyhen DS; Zamora K; Kerns RD;
    Pain Med; 2020 Dec; 21(Suppl 2):S13-S20. PubMed ID: 33313726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How pragmatic is it? Lessons learned using PRECIS and RE-AIM for determining pragmatic characteristics of research.
    Gaglio B; Phillips SM; Heurtin-Roberts S; Sanchez MA; Glasgow RE
    Implement Sci; 2014 Aug; 9():96. PubMed ID: 25163664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and Implementation of the Military Treatment Facility Engagement Committee (MTFEC) to Support Pragmatic Clinical Trials in the Military Health System.
    Scarton DV; Roddy WT; Taylor JA; Geda M; Brandt CA; Peduzzi P; Kerns RD; Pasquina PF
    Mil Med; 2021 Jan; 186(Suppl 1):70-75. PubMed ID: 33499543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Considerations When Designing and Implementing Pragmatic Clinical Trials That Include Older Hispanics.
    Samper-Ternent R; Silveira SL; Stevens A; Volpi E; Naik AD
    Ethn Dis; 2023 Apr; 33(2-3):76-83. PubMed ID: 38845738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of PRECIS ratings in the National Institutes of Health (NIH) Health Care Systems Research Collaboratory.
    Johnson KE; Neta G; Dember LM; Coronado GD; Suls J; Chambers DA; Rundell S; Smith DH; Liu B; Taplin S; Stoney CM; Farrell MM; Glasgow RE
    Trials; 2016 Jan; 17():32. PubMed ID: 26772801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Framing the conversation: use of PRECIS-2 ratings to advance understanding of pragmatic trial design domains.
    Lipman PD; Loudon K; Dluzak L; Moloney R; Messner D; Stoney CM
    Trials; 2017 Nov; 18(1):532. PubMed ID: 29126437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do randomized controlled nursing trials have a pragmatic or explanatory attitude? Findings from the Pragmatic-Explanatory Continuum Indicator Summary (PRECIS) tool exercise.
    Palese A; Bevilacqua MG; Dante A;
    J Nurs Res; 2014 Sep; 22(3):216-20. PubMed ID: 25111115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Designing provider-focused implementation trials with purpose and intent: introducing the PRECIS-2-PS tool.
    Norton WE; Loudon K; Chambers DA; Zwarenstein M
    Implement Sci; 2021 Jan; 16(1):7. PubMed ID: 33413489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The PRECIS-2 tool: designing trials that are fit for purpose].
    Hu GP; Zhan SY
    Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Feb; 39(2):222-226. PubMed ID: 29495210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.